Latest news
Arcutis Biotherapeutics (NASDAQ:ARQT) Raised to "Strong-Buy" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:38:56 GMTAnalysts Set Expectations for ARQT Q1 Earnings - MarketBeatMarketBeat · Fri, 07 Aug 2026 10:56:49 GMTArcutis Biotherapeutics (NASDAQ:ARQT) Given New $40.00 Price Target at Needham & Company LLC - MarketBeatMarketBeat · Thu, 06 Aug 2026 18:05:40 GMTArcutis Biotherapeutics (NASDAQ:ARQT) Insider Patrick Burnett Sells 955 Shares of Stock - MarketBeatMarketBeat · Thu, 06 Aug 2026 03:40:57 GMTInsider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $114,275.00 in Stock - MarketBeatMarketBeat · Thu, 06 Aug 2026 03:24:32 GMTArcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $32,127.60 in Stock - MarketBeatMarketBeat · Thu, 06 Aug 2026 03:19:08 GMTArcutis Biotherapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 22:03:50 GMTThe Manufacturers Life Insurance Company Raises Holdings in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeatMarketBeat · Mon, 03 Aug 2026 09:27:10 GMT